Samil Pharm Cash Flow Quality Index
Samil Pharm cash flow quality index. Samil Pharm (000520) has a Cash Flow Quality Index of 5.01x as of June 2024. Operating cash flow of ₩1.75 Billion exceeds net income of ₩350.31 Million, indicating high earnings quality where cash backs reported profits. Explore 000520 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Samil Pharm (2013–2023)
Cash flow quality index of Samil Pharm from 2013 to 2023. Historical Cash Flow Quality Index for Samil Pharm across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. See 000520 net asset quality score to measure how much of total assets are equity-financed.
Samil Pharm Cash Flow Quality Index by Year (2013–2023)
Samil Pharm cash flow quality index by year from 2013 to 2023. Year-by-year earnings quality comparison for Samil Pharm. For the full cash flow conversion analysis, see 000520 cash flow conversion.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 7.06x | ₩11.75 Billion | ₩1.66 Billion | ▲ +21.7% |
| 2020 | 5.80x | ₩7.77 Billion | ₩1.34 Billion | ▼ -56.9% |
| 2019 | 13.47x | ₩10.59 Billion | ₩786.26 Million | ▲ +111.9% |
| 2016 | 6.35x | ₩5.63 Billion | ₩886.60 Million | ▲ +28.1% |
| 2015 | 4.96x | ₩2.92 Billion | ₩588.37 Million | ▲ +1086.3% |
| 2013 | -0.50x | ₩-3.99 Billion | ₩7.93 Billion | — |